MedPath

Hikma Labs Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

Bioequivalency Study of Montelukast Chewable 5 mg Tablets Under Fed Conditions

Early Phase 1
Completed
Conditions
Asthma
Interventions
First Posted Date
2012-08-08
Last Posted Date
2018-01-23
Lead Sponsor
Roxane Laboratories
Target Recruit Count
36
Registration Number
NCT01659892
Locations
🇺🇸

PRACS Institute, Ltd., Fargo, North Dakota, United States

Bioequivalency Study of Montelukast 10 mg Tablets Under Fasted Conditions

Early Phase 1
Completed
Conditions
Asthma
Interventions
First Posted Date
2012-08-08
Last Posted Date
2018-01-23
Lead Sponsor
Roxane Laboratories
Target Recruit Count
34
Registration Number
NCT01659931
Locations
🇺🇸

PRACS Institute, Ltd., Fargo, North Dakota, United States

Bioequivalency Study of Montelukast 10 mg Tablets Under Fed Conditions

Early Phase 1
Completed
Conditions
Asthma
Interventions
First Posted Date
2012-08-08
Last Posted Date
2018-01-23
Lead Sponsor
Roxane Laboratories
Target Recruit Count
35
Registration Number
NCT01659918
Locations
🇺🇸

PRACS Institute, Ltd., Fargo, North Dakota, United States

Bioequivalency Study of Montelukast Chewable 5 mg Tablets Under Fasted Conditions

Early Phase 1
Completed
Conditions
Asthma
Interventions
First Posted Date
2012-08-08
Last Posted Date
2018-01-23
Lead Sponsor
Roxane Laboratories
Target Recruit Count
35
Registration Number
NCT01659905
Locations
🇺🇸

PRACS Institute, Ltd., Fargo, North Dakota, United States

Crossover Bioequivalence Study of Tinidazole 500 mg Tablets Under Fed Conditions

Phase 1
Completed
Conditions
Trichomoniasis
Interventions
First Posted Date
2012-05-04
Last Posted Date
2018-01-23
Lead Sponsor
Roxane Laboratories
Target Recruit Count
28
Registration Number
NCT01591889
Locations
🇺🇸

Novum Pharmaceutical Research Services, Houston, Texas, United States

Crossover Bioequivalence Study of Quetiapine Fumarate 25 mg Tablets Under Fasted Conditions

Not Applicable
Completed
Conditions
Treatment for Bipolar I Disorder
First Posted Date
2012-04-04
Last Posted Date
2018-01-23
Lead Sponsor
Roxane Laboratories
Target Recruit Count
42
Registration Number
NCT01570907
Locations
🇺🇸

Novum Pharmaceutical Research Services, Houston, Texas, United States

Crossover Bioequivalence Study of Quetiapine Fumarate 25 mg Tablets Under Fed Conditions

Not Applicable
Completed
Conditions
Bipolar I Disorder
First Posted Date
2012-04-04
Last Posted Date
2018-01-23
Lead Sponsor
Roxane Laboratories
Target Recruit Count
42
Registration Number
NCT01570894
Locations
🇺🇸

Novum Pharmaceutical Research Services, Houston, Texas, United States

Crossover Bioequivalence Study of Quetiapine Fumarate 300 mg Tablets Under Steady State Fasted Conditions

Not Applicable
Completed
Conditions
Bipolar I Disorder
First Posted Date
2012-04-04
Last Posted Date
2018-01-23
Lead Sponsor
Roxane Laboratories
Target Recruit Count
56
Registration Number
NCT01570959
Locations
🇺🇸

Global Medical Institutes/Princeton Medical Institute, Princeton, New Jersey, United States

🇺🇸

Collaborative Neuroscience Network, Inc., Garden Grove, California, United States

🇺🇸

Community Clinical Research, Inc., Austin, Texas, United States

and more 4 locations

Bioequivalency Study of Letrozole 2.5 mg Tablets Under Fed Conditions

Phase 1
Completed
Conditions
Breast Cancer
Interventions
First Posted Date
2011-06-07
Last Posted Date
2018-01-23
Lead Sponsor
Roxane Laboratories
Target Recruit Count
28
Registration Number
NCT01367626
Locations
🇺🇸

PRACS Institute, Ltd., Fargo, North Dakota, United States

Bioequivalency Study of Letrozole 2.5 mg Tablets Under Fasted Conditions

Phase 1
Completed
Conditions
Breast Cancer
Interventions
First Posted Date
2011-06-07
Last Posted Date
2018-01-23
Lead Sponsor
Roxane Laboratories
Target Recruit Count
28
Registration Number
NCT01367652
Locations
🇺🇸

PRACS Institute, Ltd., Fargo, North Dakota, United States

© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy